Middle East and Africa Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment Type (Nicotine Addiction Treatment, Alcohol Addiction Treatment, Opioid Addiction Treatment, Other Substance Addiction Treatment); Drug Type (Varenicline, Bupropion, Nicotine Replacement Products, Buprenorphine, Naltrexone, Disulfiram, Others); Treatment Center (Outpatient Treatment Center, Residential Treatment Center, Inpatient Treatment Center); Distribution Channel (Hospitals, Medical Stores, Others) and Country

TIPRE00017278 | Pages: 87 | Pharmaceuticals | Dec 2020 | Type: Regional | Status: Published

Market Introduction

Addiction is a psychological and physical inability to stop consuming drugs, alcohol, opioids, and related category substances, even though those substances have various mental and physical harms. An addiction develops dependency in a person to take that substance. So, to stop addictions, there are several options available such as drug therapy, rehabilitation, which can stop addiction in a better way.

 


Get more information on this report :



Market Overview and Dynamics

The Middle East and Africa Addictions Therapeutics market is expected to reach US$ 223.05 million in 2027 from US$ 172.05 million in 2019. The market is estimated to grow with a CAGR of 3.4% from 2020 to 2027. The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high cost associated with drug development is hindering the growth of the addiction therapeutics market.

 

Key Market Segments

Based on treatment type, the Europe addictions therapeutics market is segmented into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and other substance addiction treatment. The nicotine addiction treatment segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

The Europe addictions therapeutics market, by drug type, is segmented into varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment held the largest market share in 2019. However, the nicotine replacement products segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on treatment center, the Europe addictions therapeutics market is segmented into outpatient treatment center, residential treatment center, and inpatient treatment center. In 2019, the outpatient treatment center segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.

By distribution channel, the Europe addictions therapeutics market is segmented into hospital pharmacies, medical stores, and others. The hospital pharmacies segment held the largest share of the market in 2019. However, the medical stores segment is estimated to register the highest CAGR in the market during the forecast period.

 

Major Sources and Companies Listed

Some of the primary and secondary sources associated with this report on the Middle East and Africa addictions therapeutics market are Federation of African Pharmaceutical Manufacturers’ Associations (FAPMA); Centers for Disease Control and Prevention (CDC); South African National Council on Alcoholism and Drug Dependence (SANCA) among others.

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of the Middle East and Africa addictions therapeutics market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the Middle East and Africa addictions therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa addictions therapeutics market.

 

 

MIDDLE EAST AND AFRICA ADDICTIONS THERAPEUTICS MARKET SEGMENTATION

 By Treatment Type

  • Opioid Addiction Treatment
  • Alcohol Addiction Treatment
  • Nicotine Addiction Treatment
  • Other Substance Addiction Treatment

 

By Drug Type

  • Buprenorphine
  • Naltrexone
  • Bupropion
  • Disulfiram
  • Nicotine Replacement Products
  • Varenicline
  • Others

 

By Treatment Center

  • Inpatient Treatment Center
  • Residential Treatment Center
  • Outpatient Treatment Center

 

By Distribution Channel

  • Hospital Pharmacies
  • Medical stores
  • Others

 

By Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

 

Company Profiles

  • Indivior PLC
  • GlaxoSmithKline plc
  • Bausch Health Companies Inc
  • Cipla Inc.
  • Alvogen
  • Camurus AB
  • Hikma Pharmaceuticals PLC
 

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East and Africa Addictions Therapeutics Market – By Treatment Type

1.3.2 Middle East and Africa Addictions Therapeutics Market – By Drug Type

1.3.3 Middle East and Africa Addictions Therapeutics Market – By Treatment Center

1.3.4 Middle East and Africa Addictions Therapeutics Market – By Distribution Channel

1.3.5 Middle East and Africa Addictions Therapeutics Market – By Country

2. Addictions Therapeutics Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Addiction Therapeutics Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Middle East and Africa (MEA)– PEST Analysis

5. Addiction Therapeutics Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Addiction Among General Populace

5.1.2 Conduction of Awareness Campaigns

5.2 Market Restraint

5.2.1 Steeping Costs of Drug Development

5.3 Market Opportunity

5.3.1 Rising Demand for R&D from Contract Organizations

5.4 Future Trend

5.4.1 Consistent Launch of Therapeutics

5.5 Impact Analysis

6. Addiction Therapeutics Market – Middle East and Africa Analysis

6.1 Middle East and Africa Addictions Therapeutics Marker Revenue Forecast and Analysis

7. Addictions Therapeutics Market– Treatment Type

7.1 Overview

7.2 Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)

7.3 Nicotine Addiction Treatment

7.3.1 Overview

7.3.1.1 Nicotine Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

7.4 Alcohol Addiction Treatment

7.4.1 Overview

7.4.1.1 Alcohol Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

7.5 Opioid Addiction Treatment

7.5.1 Overview

7.5.1.1 Opioid Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

7.6 Other Substance Addiction Treatment

7.6.1 Overview

7.6.2 Other Substance Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8. Addictions Therapeutics Market– Drug Type

8.1 Overview

8.2 Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)

8.3 Varenicline

8.3.1 Overview

8.3.1.1 Varenicline: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.4 Bupropion

8.4.1 Overview

8.4.1.1 Bupropion: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.5 Nicotine Replacement Products

8.5.1 Overview

8.5.1.1 Nicotine Replacement Products: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.6 Buprenorphine

8.6.1 Overview

8.6.1.1 Buprenorphine: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.7 Naltrexone

8.7.1 Overview

8.7.1.1 Naltrexone: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.8 Disulfiram

8.8.1 Overview

8.8.1.1 Disulfiram: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.9 Others

8.9.1 Overview

8.9.1.1 Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

9. Addictions Therapeutics Market– Treatment Centre

9.1 Overview

9.2 Addictions Therapeutics Market Share, Treatment Centre, 2019 and 2027 (%)

9.3 Outpatient Treatment Centre

9.3.1 Overview

9.3.1.1 Outpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

9.4 Residential Treatment Center

9.4.1 Overview

9.4.1.1 Residential Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

9.5 Inpatient Treatment Center

9.5.1 Overview

9.5.1.1 Inpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

10. Addictions Therapeutics Market– Distribution Channel

10.1 Overview

10.2 Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)

10.3 Hospital Pharmacies

10.3.1 Overview

10.3.1.1 Hospital Pharmacies: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

10.4 Medical Stores

10.4.1 Overview

10.4.1.1 Medical Stores: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

10.5 Others

10.5.1 Overview

10.5.1.1 Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

11. Addiction Therapeutics Market Analysis and Forecasts To 2027 – Middle East and Africa Analysis

11.1 Middle East & Africa: Addiction Therapeutics Market

11.1.1 Overview

11.1.2 Middle East & Africa: Addiction Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)

11.1.3 Middle East and Africa Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

11.1.4 Middle East and Africa Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

11.1.5 Middle East and Africa Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)

11.1.5.1 Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.6 Middle East & Africa: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)

11.1.7 Saudi Arabia: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.7.1 Saudi Arabia: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.7.2 Saudi Arabia Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

11.1.7.3 Saudi Arabia Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

11.1.7.4 Saudi Arabia Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)

11.1.7.5 Saudi Arabia: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.8 UAE: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1 UAE: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2 UAE Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

11.1.8.3 UAE Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

11.1.8.4 UAE Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)

11.1.8.5 UAE: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.9 South Africa: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1 South Africa: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2 South Africa Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

11.1.9.3 South Africa Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

11.1.9.4 South Africa Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)

11.1.9.5 South Africa: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.10 Rest of Middle East and Africa: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1 Rest of Middle East and Africa: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2 Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

11.1.10.3 Rest of Middle East and Africa Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

11.1.10.4 Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)

11.1.10.5 Rest of Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

12. Impact of COVID-19 Pandemic on Middle East and Africa Addiction Therapeutics Market

12.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13. Company Profiles

13.1 Indivior PLC

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Pfizer Inc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 GlaxoSmithKline plc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Bausch Health Companies Inc.

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Cipla Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Hikma Pharmaceuticals PLC

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms


LIST OF TABLES

Table 1. Middle East and Africa Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

Table 2. Middle East and Africa Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

Table 3. Middle East and Africa Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)

Table 4. Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5. Saudi Arabia Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

Table 6. Saudi Arabia Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

Table 7. Saudi Arabia Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)

Table 8. Saudi Arabia: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9. UAE Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

Table 10. UAE Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

Table 11. UAE Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)

Table 12. UAE: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13. South Africa Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

Table 14. South Africa Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

Table 15. South Africa Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)

Table 16. South Africa: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17. Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

Table 18. Rest of Middle East and Africa Addiction Therapeutics Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)

Table 19. Rest of Middle East and Africa Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027(USD Million)

Table 20. Rest of Middle East and Africa: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21. Glossary of Terms, Medical Adhesive and Sealants Market

 


LIST OF FIGURES

Figure 1. Addictions Therapeutics Market Segmentation

Figure 2. Addictions Therapeutics Market – By Country

Figure 3. Addictions Therapeutics Market Overview

Figure 4. Nicotine Addiction Treatment Segment Held Largest Share of Addictions Therapeutics Market

Figure 5. Middle East and Africa Addictions Therapeutics Market – Leading Country Markets (US$ Million)

Figure 6. Middle East and Africa (MEA)PEST Analysis

Figure 7. Addiction Therapeutics Market Impact Analysis of Drivers and Restraint

Figure 8. Middle East and Africa Addictions Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027

Figure 9. Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)

Figure 10. Nicotine Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 11. Alcohol Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 12. Opioid Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 13. Other Substance Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 14. Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)

Figure 15. Varenicline: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 16. Bupropion: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 17. Nicotine Replacement Products: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 18. Buprenorphine: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 19. Naltrexone: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 20. Disulfiram: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 21. Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 22. Addictions Therapeutics Market Share, Treatment Center, 2019 and 2027 (%)

Figure 23. Outpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 24. Residential Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 25. Inpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 26. Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)

Figure 27. Hospital Pharmacies: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 28. Medical Stores: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 29. Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 30. Middle East & Africa: Addiction Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

Figure 31. Middle East & Africa Addiction Therapeutics Market Revenue and Forecast to 2027 (USD Million)

Figure 32. Middle East & Africa: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)

Figure 33. Saudi Arabia: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 34. UAE: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35. South Africa: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 36. Rest of Middle East and Africa: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 37. Impact Of COVID-19 Pandemic in Middle East and Africa Countries Market

 

 

  1. Indivior PLC
  2. GlaxoSmithKline plc
  3. Bausch Health Companies Inc
  4. Cipla Inc.
  5. Alvogen
  6. Camurus AB
  7. Hikma Pharmaceuticals PLC
  • Determine prospective investment areas based on a detailed trend analysis of the Middle East and Africa addictions therapeutics market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the Middle East and Africa addictions therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa addictions therapeutics market.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000